BioDirection Selected To Present At Cavendish Global Health Impact Forum

BOSTON--(BUSINESS WIRE)--BioDirection, Inc., an emerging medical device company focused on the development and commercialization of rapid, affordable point-of-care devices for the early identification of mild traumatic brain injury (concussion), announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place May 10th to May 14th in La Jolla, California.

Help employers find you! Check out all the jobs and post your resume.